SuspendedPhase 2NCT01887457

Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy

Studying Aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Brynn Chappell
Principal Investigator
William Hope
University of Liverpool
Intervention
VFEND(drug)
Enrollment
33 enrolled
Eligibility
18 years · All sexes
Timeline
20142016

Study locations (1)

Collaborators

The Christie NHS Foundation Trust

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01887457 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis

← Back to all trials